Literature DB >> 12606137

Cytogenetic findings in benign cartilaginous neoplasms.

Emilie P Buddingh1, Sabine Naumann, Marilu Nelson, James R Neffa, Nathan Birch, Julia A Bridge.   

Abstract

Cytogenetic analysis has improved our understanding of the histopathogenesis of many benign and malignant bone and soft tissue tumors, as well as served as an important diagnostic adjunct for these pathologic entities. Cytogenetic reports of benign cartilaginous tumors, however, are relatively few. This is unfortunate, as distinguishing benign and malignant cartilaginous neoplasms can often be difficult. In this study, the cytogenetic findings of two enchondromas, two periosteal chondromas, and one soft part chondroma and a review of the literature are reported. Abnormal diploid or near-diploid clones were detected in all specimens analyzed. Although a tumor-specific anomaly did not emerge from these studies, involvement of certain chromosomes/chromosomal regions appears recurrent.

Entities:  

Mesh:

Year:  2003        PMID: 12606137     DOI: 10.1016/s0165-4608(02)00726-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Analysis of chromosomal imbalances in an elderly woman with a giant cell tumour.

Authors:  Juan Luis García; Cristina Robledo; E Lumbreras; Teresa Flores; Luis Ramos; Jesús M Hernández
Journal:  Virchows Arch       Date:  2005-10-12       Impact factor: 4.064

2.  Recurrent 12q13-15 chromosomal aberrations, high frequency of isocitrate dehydrogenase 1 mutations, and absence of high mobility group AT-hook 2 expression in periosteal chondromas.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Ingeborg Taksdal; Bodil Bjerkehagen; Sverre Heim
Journal:  Oncol Lett       Date:  2015-05-11       Impact factor: 2.967

Review 3.  Molecular pathology of chondroid neoplasms: part 1, benign lesions.

Authors:  W C Bell; M J Klein; M J Pitt; G P Siegal
Journal:  Skeletal Radiol       Date:  2006-09-23       Impact factor: 2.199

4.  C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma.

Authors:  Dali Huang; Janos Sumegi; Paola Dal Cin; John D Reith; Taketoshi Yasuda; Marilu Nelson; David Muirhead; Julia A Bridge
Journal:  Genes Chromosomes Cancer       Date:  2010-09       Impact factor: 5.006

5.  Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes.

Authors:  Salvatore Romeo; Ronald A J Duim; Julia A Bridge; Fredrik Mertens; Danielle de Jong; Paola Dal Cin; Pauline M Wijers-Koster; Maria Debiec-Rychter; Raf Sciot; Andrew E Rosenberg; Karoly Szuhai; Pancras C W Hogendoorn
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

6.  Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondroma.

Authors:  Ioannis Panagopoulos; Bodil Bjerkehagen; Ludmila Gorunova; Ingeborg Taksdal; Sverre Heim
Journal:  Oncol Rep       Date:  2015-06-05       Impact factor: 3.906

Review 7.  Benign Bone Tumors: An Overview of What We Know Today.

Authors:  Sara De Salvo; Vito Pavone; Sebastiano Coco; Eleonora Dell'Agli; Chiara Blatti; Gianluca Testa
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.